CFA
TEVA icon

Carroll Financial Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Carroll Financial Associates’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-543
Closed -$5K – 1707
2019
Q2 		$5K Buy
543
+3
+0.6% +$36 ﹤0.01% 1217
2019
Q1 		$8K Hold
540
– – ﹤0.01% 1007
2018
Q4 		$9K Hold
540
– – ﹤0.01% 896
2018
Q3 		$11K Hold
540
– – ﹤0.01% 875
2018
Q2 		$13K Hold
540
– – ﹤0.01% 804
2018
Q1 		$9K Hold
540
– – ﹤0.01% 866
2017
Q4 		$10K Sell
540
-1,000
-65% -$15K ﹤0.01% 832
2017
Q3 		$24K Sell
1,540
-243
-14% -$5.47K ﹤0.01% 616
2017
Q2 		$59K Buy
1,783
+1
+0.1% +$31 0.01% 462
2017
Q1 		$57K Sell
1,782
-744
-29% -$25.4K 0.01% 452
2016
Q4 		$91K Sell
2,526
-719
-22% -$28.7K 0.01% 362
2016
Q3 		$149K Sell
3,245
-4
-0.1% -$209 0.02% 282
2016
Q2 		$163K Buy
3,249
+100
+3% +$5.32K 0.03% 256
2016
Q1 		$168K Buy
3,149
+24
+0.8% +$1.41K 0.03% 241
2015
Q4 		$205K Hold
3,125
– – 0.04% 207
2015
Q3 		$181K Sell
3,125
-128
-4% -$8.3K 0.04% 211
2015
Q2 		$192K Buy
3,253
+964
+42% +$59.5K 0.04% 197
2015
Q1 		$143K Hold
2,289
– – 0.06% 163
2014
Q4 		$129K Sell
2,289
-1,104
-33% -$61.5K 0.08% 143
2014
Q3 		$197K Sell
3,393
-57
-2% -$3.02K 0.06% 152
2014
Q2 		$181K Buy
3,450
+118
+4% +$6.03K 0.05% 166
2014
Q1 		$176K Hold
3,332
– – 0.06% 154
2013
Q4 		$133K Sell
3,332
-300
-8% -$11.8K 0.05% 178
2013
Q3 		$137K Buy
+3,632
New +$142K 0.05% 173

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Carroll Financial Associates's TEVA Position: Q3 2019 in Review

Carroll Financial Associates sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 543 shares — an estimated $5K sold.

Carroll Financial Associates first reported a position in TEVA in Q3 2013 and held it in 24 quarters. The position peaked at $205K in Q4 2015. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Carroll Financial Associates reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Carroll Financial Associates sold 543 Teva Pharmaceuticals shares in Q3 2019, an estimated $5K.
  • Carroll Financial Associates first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 24 quarters.
  • Carroll Financial Associates's Teva Pharmaceuticals position peaked at $205K in Q4 2015.
  • 427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Carroll Financial Associates's 13F filing for Q3 2019, filed 9 Oct 2019.